Bindu Murthy

<scp>First‐in‐human</scp> study of deucravacitinib: A selective, potent, allosteric <scp>small‐molecule</scp> inhibitor of tyrosine kinase 2

Ian M. Catlett, Urvi Aras, Lars Hansen et al. · Clinical and Translational Science · 2022 · 52 citations · Full text

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects

Rong Shi, Marek Honczarenko, Sean X. Zhang et al. · The Journal of Clinical Pharmacology · 2016 · 43 citations · Full text

Healthy Subjects, Immunology, Pharmacotherapy +20

Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis

René Westhovens, Manuel Robles, Antônio Carlos Ximenes et al. · Annals of the Rheumatic Diseases · 2014 · 42 citations · Full text

Soft-Tissue Penetration of Ceftobiprole in Healthy Volunteers Determined by In Vivo Microdialysis

April Barbour, Stephan Schmidt, Sreedharan Sabarinath et al. · Antimicrobial Agents and Chemotherapy · 2009 · 39 citations · Full text

Pharmaceutical Science, Dialysis Therapy, Antimicrobial Chemotherapy +20

Safety, pharmacokinetics, and pharmacodynamics of BMS-986142, a novel reversible BTK inhibitor, in healthy participants

Sun Ku Lee, Jun Xing, Ian M. Catlett et al. · European Journal of Clinical Pharmacology · 2017 · 39 citations · Full text